Zenith Drugs Limited IPO
Zenith Drugs Limited was a SME IPO in the Pharmaceuticals sector, offered at ₹75–₹79 per share to raise ₹41 crore. It listed on 27 Feb 2024 at ₹110 and closed its first day at ₹105, a listing gain of +33.1% versus the ₹79 issue price. It now trades around ₹37 (-53.2% versus the issue price).
Frequently asked questions
- What were the Zenith Drugs Limited IPO listing gains?
- Zenith Drugs Limited listed on 27 Feb 2024 at ₹110, closing its first day at ₹105 — a listing gain of +33.1% versus the ₹79 issue price.
- What was the price band and lot size of the Zenith Drugs Limited IPO?
- The price band was ₹75–₹79 per share, with a minimum lot of 1,600 shares (₹1,26,400 at the upper band).
- Who were the registrar and lead manager for the Zenith Drugs Limited IPO?
- Bigshare Services Private Limited was the registrar, and Gretex Corporate Services was the book-running lead manager.